Lee EJ - Search Results

1

EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression.

Yoon S, Choi JH, Kim SJ, Lee EJ, Shah M, Choi S, Woo HG. Yoon S, et al. Among authors: lee ej. Exp Mol Med. 2019 Jun 3;51(6):1-12. doi: 10.1038/s12276-019-0261-z. Exp Mol Med. 2019. PMID: 31160603 Free PMC article.

2

AGR2, a mucinous ovarian cancer marker, promotes cell proliferation and migration.

Park K, Chung YJ, So H, Kim K, Park J, Oh M, Jo M, Choi K, Lee EJ, Choi YL, Song SY, Bae DS, Kim BG, Lee JH. Park K, et al. Among authors: lee ej, lee jh. Exp Mol Med. 2011 Feb 28;43(2):91-100. doi: 10.3858/emm.2011.43.2.011. Exp Mol Med. 2011. PMID: 21200134 Free PMC article.

3

Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer.

Yoon S, Lee EJ, Choi JH, Chung T, Kim DY, Im JY, Bae MH, Kwon JH, Kim HH, Kim HC, Park YN, Wang HJ, Woo HG. Yoon S, et al. Among authors: lee ej. Oncogene. 2018 Aug;37(32):4443-4454. doi: 10.1038/s41388-018-0291-3. Epub 2018 May 3. Oncogene. 2018. PMID: 29720727

4

Identification of novel susceptibility loci associated with hepatitis B surface antigen seroclearance in chronic hepatitis B.

Kim TH, Lee EJ, Choi JH, Yim SY, Lee S, Kang J, Lee YR, Lee HA, Choi HS, Kim ES, Keum B, Seo YS, Yim HJ, Jeen YT, Chun HJ, Lee HS, Kim CD, Woo HG, Um SH. Kim TH, et al. Among authors: lee ej, lee yr, lee ha, lee hs, lee s. PLoS One. 2018 Jul 5;13(7):e0199094. doi: 10.1371/journal.pone.0199094. eCollection 2018. PLoS One. 2018. PMID: 29975729 Free PMC article.

5

Reduced expression of DRAM2/TMEM77 in tumor cells interferes with cell death.

Park SM, Kim K, Lee EJ, Kim BK, Lee TJ, Seo T, Jang IS, Lee SH, Kim S, Lee JH, Park J. Park SM, et al. Among authors: lee ej, lee sh, lee tj, lee jh. Biochem Biophys Res Commun. 2009 Dec 25;390(4):1340-4. doi: 10.1016/j.bbrc.2009.10.149. Epub 2009 Nov 4. Biochem Biophys Res Commun. 2009. PMID: 19895784

6

6-Azauridine Induces Autophagy-Mediated Cell Death via a p53- and AMPK-Dependent Pathway.

Cha YE, Park R, Jang M, Park YI, Yamamoto A, Oh WK, Lee EJ, Park J. Cha YE, et al. Among authors: lee ej. Int J Mol Sci. 2021 Mar 14;22(6):2947. doi: 10.3390/ijms22062947. Int J Mol Sci. 2021. PMID: 33799444 Free PMC article.

7

Luteolin exerts anti-tumor activity through the suppression of epidermal growth factor receptor-mediated pathway in MDA-MB-231 ER-negative breast cancer cells.

Lee EJ, Oh SY, Sung MK. Lee EJ, et al. Food Chem Toxicol. 2012 Nov;50(11):4136-43. doi: 10.1016/j.fct.2012.08.025. Epub 2012 Aug 20. Food Chem Toxicol. 2012. PMID: 22926442

8

Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.

Nguyen TM, Shin IW, Lee TJ, Park J, Kim JH, Park MS, Lee EJ. Nguyen TM, et al. Among authors: lee ej, lee tj. Gynecol Oncol. 2016 Mar;140(3):545-53. doi: 10.1016/j.ygyno.2015.12.006. Epub 2015 Dec 12. Gynecol Oncol. 2016. PMID: 26691219

9

Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression.

Shin HY, Yang W, Lee EJ, Han GH, Cho H, Chay DB, Kim JH. Shin HY, et al. Among authors: lee ej. PLoS One. 2018 Oct 8;13(10):e0205297. doi: 10.1371/journal.pone.0205297. eCollection 2018. PLoS One. 2018. PMID: 30296284 Free PMC article.

10

AMP-activated protein kinase regulates the expression of human telomerase reverse transcriptase.

Jo D, Park R, Kim H, Jang M, Lee EJ, Jang IS, Park J. Jo D, et al. Among authors: lee ej. PLoS One. 2018 Nov 26;13(11):e0207864. doi: 10.1371/journal.pone.0207864. eCollection 2018. PLoS One. 2018. PMID: 30475873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,959 results

Search Page